Tyra Biosciences (TYRA) Equity Ratio (2020 - 2026)
Quarterly Equity Ratio changed 0.14% to 0.94 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.94 through Mar 2026, changed 0.14% year-over-year, with the annual reading at 0.92 for FY2025, 2.84% down from the prior year.
Tyra Biosciences filings provide 7 years of Equity Ratio readings, the most recent being 0.94 for Q1 2026.
- Equity Ratio hit 0.94 in Q1 2026 for Tyra Biosciences, up from 0.92 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.98 in Q1 2023 and bottomed at 0.9 in Q4 2023.
- Average Equity Ratio over 5 years is 0.95, with a median of 0.95 recorded in 2024.
- The largest annual shift saw Equity Ratio decreased 6.63% in 2023 before it rose 4.37% in 2024.
- Tyra Biosciences' Equity Ratio stood at 0.97 in 2022, then decreased by 6.63% to 0.9 in 2023, then rose by 4.37% to 0.94 in 2024, then decreased by 2.84% to 0.92 in 2025, then increased by 2.57% to 0.94 in 2026.
- Per Business Quant, the three most recent readings for TYRA's Equity Ratio are 0.94 (Q1 2026), 0.92 (Q4 2025), and 0.93 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.73 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.77 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.21 |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 0.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.94 |
| Dec 31, 2025 | 0.92 |
| Sep 30, 2025 | 0.93 |
| Jun 30, 2025 | 0.94 |
| Mar 31, 2025 | 0.94 |
| Dec 31, 2024 | 0.94 |
| Sep 30, 2024 | 0.95 |
| Jun 30, 2024 | 0.96 |
| Mar 31, 2024 | 0.96 |
| Dec 31, 2023 | 0.90 |
| Sep 30, 2023 | 0.93 |
| Jun 30, 2023 | 0.95 |
| Mar 31, 2023 | 0.98 |
| Dec 31, 2022 | 0.97 |
| Sep 30, 2022 | 0.97 |
| Jun 30, 2022 | 0.97 |
| Mar 31, 2022 | 0.97 |
| Dec 31, 2021 | 0.98 |
| Sep 30, 2021 | 0.98 |
| Dec 31, 2020 | -0.85 |